The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Saxagliptin API Market Research Report 2025
Synopsis
Saxagliptin is a highly effective dipeptidase -4 inhibitor. By selectively inhibiting dpp-4, endogenous levels of glucagon-like peptide-1 and glucose-dependent insulin-releasing peptides can be increased to regulate blood glucose.
The global Saxagliptin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Saxagliptin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Saxagliptin API.
Report Scope
The Saxagliptin API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Saxagliptin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Saxagliptin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Tapi Teva
API Polpharma
Metrochem API
Tianjin Scipharmacn
Taizhou Canova Bio-technology
Minxiang Pharma
Huaman Xincaiiao Keji
Jinan Lead Pharm-Chemical
Hebei Kangtai Pharma
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Saxagliptin Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Saxagliptin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Saxagliptin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Saxagliptin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Saxagliptin is a highly effective dipeptidase -4 inhibitor. By selectively inhibiting dpp-4, endogenous levels of glucagon-like peptide-1 and glucose-dependent insulin-releasing peptides can be increased to regulate blood glucose.
The global Saxagliptin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Saxagliptin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Saxagliptin API.
Report Scope
The Saxagliptin API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Saxagliptin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Saxagliptin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Tapi Teva
API Polpharma
Metrochem API
Tianjin Scipharmacn
Taizhou Canova Bio-technology
Minxiang Pharma
Huaman Xincaiiao Keji
Jinan Lead Pharm-Chemical
Hebei Kangtai Pharma
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Saxagliptin Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Saxagliptin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Saxagliptin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Saxagliptin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Saxagliptin API Market Overview
1.1 Product Definition
1.2 Saxagliptin API Segment by Type
1.2.1 Global Saxagliptin API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Saxagliptin API Segment by Application
1.3.1 Global Saxagliptin API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Saxagliptin Tablets
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Saxagliptin API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Saxagliptin API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Saxagliptin API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Saxagliptin API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Saxagliptin API Production Market Share by Manufacturers (2019-2024)
2.2 Global Saxagliptin API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Saxagliptin API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Saxagliptin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Saxagliptin API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Saxagliptin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Saxagliptin API, Product Offered and Application
2.8 Global Key Manufacturers of Saxagliptin API, Date of Enter into This Industry
2.9 Saxagliptin API Market Competitive Situation and Trends
2.9.1 Saxagliptin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Saxagliptin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Saxagliptin API Production by Region
3.1 Global Saxagliptin API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Saxagliptin API Production Value by Region (2019-2030)
3.2.1 Global Saxagliptin API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Saxagliptin API by Region (2025-2030)
3.3 Global Saxagliptin API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Saxagliptin API Production by Region (2019-2030)
3.4.1 Global Saxagliptin API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Saxagliptin API by Region (2025-2030)
3.5 Global Saxagliptin API Market Price Analysis by Region (2019-2024)
3.6 Global Saxagliptin API Production and Value, Year-over-Year Growth
3.6.1 North America Saxagliptin API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Saxagliptin API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Saxagliptin API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Saxagliptin API Production Value Estimates and Forecasts (2019-2030)
4 Saxagliptin API Consumption by Region
4.1 Global Saxagliptin API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Saxagliptin API Consumption by Region (2019-2030)
4.2.1 Global Saxagliptin API Consumption by Region (2019-2024)
4.2.2 Global Saxagliptin API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Saxagliptin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Saxagliptin API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Saxagliptin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Saxagliptin API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Saxagliptin API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Saxagliptin API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Saxagliptin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Saxagliptin API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Saxagliptin API Production by Type (2019-2030)
5.1.1 Global Saxagliptin API Production by Type (2019-2024)
5.1.2 Global Saxagliptin API Production by Type (2025-2030)
5.1.3 Global Saxagliptin API Production Market Share by Type (2019-2030)
5.2 Global Saxagliptin API Production Value by Type (2019-2030)
5.2.1 Global Saxagliptin API Production Value by Type (2019-2024)
5.2.2 Global Saxagliptin API Production Value by Type (2025-2030)
5.2.3 Global Saxagliptin API Production Value Market Share by Type (2019-2030)
5.3 Global Saxagliptin API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Saxagliptin API Production by Application (2019-2030)
6.1.1 Global Saxagliptin API Production by Application (2019-2024)
6.1.2 Global Saxagliptin API Production by Application (2025-2030)
6.1.3 Global Saxagliptin API Production Market Share by Application (2019-2030)
6.2 Global Saxagliptin API Production Value by Application (2019-2030)
6.2.1 Global Saxagliptin API Production Value by Application (2019-2024)
6.2.2 Global Saxagliptin API Production Value by Application (2025-2030)
6.2.3 Global Saxagliptin API Production Value Market Share by Application (2019-2030)
6.3 Global Saxagliptin API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 AstraZeneca
7.1.1 AstraZeneca Saxagliptin API Corporation Information
7.1.2 AstraZeneca Saxagliptin API Product Portfolio
7.1.3 AstraZeneca Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 AstraZeneca Main Business and Markets Served
7.1.5 AstraZeneca Recent Developments/Updates
7.2 Tapi Teva
7.2.1 Tapi Teva Saxagliptin API Corporation Information
7.2.2 Tapi Teva Saxagliptin API Product Portfolio
7.2.3 Tapi Teva Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Tapi Teva Main Business and Markets Served
7.2.5 Tapi Teva Recent Developments/Updates
7.3 API Polpharma
7.3.1 API Polpharma Saxagliptin API Corporation Information
7.3.2 API Polpharma Saxagliptin API Product Portfolio
7.3.3 API Polpharma Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 API Polpharma Main Business and Markets Served
7.3.5 API Polpharma Recent Developments/Updates
7.4 Metrochem API
7.4.1 Metrochem API Saxagliptin API Corporation Information
7.4.2 Metrochem API Saxagliptin API Product Portfolio
7.4.3 Metrochem API Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Metrochem API Main Business and Markets Served
7.4.5 Metrochem API Recent Developments/Updates
7.5 Tianjin Scipharmacn
7.5.1 Tianjin Scipharmacn Saxagliptin API Corporation Information
7.5.2 Tianjin Scipharmacn Saxagliptin API Product Portfolio
7.5.3 Tianjin Scipharmacn Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Tianjin Scipharmacn Main Business and Markets Served
7.5.5 Tianjin Scipharmacn Recent Developments/Updates
7.6 Taizhou Canova Bio-technology
7.6.1 Taizhou Canova Bio-technology Saxagliptin API Corporation Information
7.6.2 Taizhou Canova Bio-technology Saxagliptin API Product Portfolio
7.6.3 Taizhou Canova Bio-technology Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Taizhou Canova Bio-technology Main Business and Markets Served
7.6.5 Taizhou Canova Bio-technology Recent Developments/Updates
7.7 Minxiang Pharma
7.7.1 Minxiang Pharma Saxagliptin API Corporation Information
7.7.2 Minxiang Pharma Saxagliptin API Product Portfolio
7.7.3 Minxiang Pharma Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Minxiang Pharma Main Business and Markets Served
7.7.5 Minxiang Pharma Recent Developments/Updates
7.8 Huaman Xincaiiao Keji
7.8.1 Huaman Xincaiiao Keji Saxagliptin API Corporation Information
7.8.2 Huaman Xincaiiao Keji Saxagliptin API Product Portfolio
7.8.3 Huaman Xincaiiao Keji Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Huaman Xincaiiao Keji Main Business and Markets Served
7.7.5 Huaman Xincaiiao Keji Recent Developments/Updates
7.9 Jinan Lead Pharm-Chemical
7.9.1 Jinan Lead Pharm-Chemical Saxagliptin API Corporation Information
7.9.2 Jinan Lead Pharm-Chemical Saxagliptin API Product Portfolio
7.9.3 Jinan Lead Pharm-Chemical Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Jinan Lead Pharm-Chemical Main Business and Markets Served
7.9.5 Jinan Lead Pharm-Chemical Recent Developments/Updates
7.10 Hebei Kangtai Pharma
7.10.1 Hebei Kangtai Pharma Saxagliptin API Corporation Information
7.10.2 Hebei Kangtai Pharma Saxagliptin API Product Portfolio
7.10.3 Hebei Kangtai Pharma Saxagliptin API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Hebei Kangtai Pharma Main Business and Markets Served
7.10.5 Hebei Kangtai Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Saxagliptin API Industry Chain Analysis
8.2 Saxagliptin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Saxagliptin API Production Mode & Process
8.4 Saxagliptin API Sales and Marketing
8.4.1 Saxagliptin API Sales Channels
8.4.2 Saxagliptin API Distributors
8.5 Saxagliptin API Customers
9 Saxagliptin API Market Dynamics
9.1 Saxagliptin API Industry Trends
9.2 Saxagliptin API Market Drivers
9.3 Saxagliptin API Market Challenges
9.4 Saxagliptin API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
